~~<i id='DC0E1927E3'><strike id='DC0E1927E3'><tt id='DC0E1927E3'><pre id='DC0E1927E3'></pre></tt></strike></i>~~

Home» focus» fashion

fashion

author：focus 2025-09-29 21:36:36 Page View：752

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What a koala virus tells us about the human genome
Next article： Moonlake's readout produced a cash windfall. Risks remain

explore

Medical records are filled with copy

AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

HHS secretary Becerra pressed on Change HealthCare cyberattack

HealthandHumanServicesSecretaryXavierBecerratestifiesThursdayduringaSenateFinanceCommitteehearingonP

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

STAT reporters are Pulitzer Prize finalists for investigative reporting

STATDearReaders,WeareenormouslyproudthatSTATreportersCaseyRossandBobHermanhavebeennamedfinalistsfort